LCA Joins Efforts to Protect Patient Access to Treatments
January 17, 2019
The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare.
The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare. They Six Protected Classes at stake include therapies for epilepsy, mental illness, cancer, HIV, and organ transplants.
The ads will be featured in The Washington Post, The New york Times, The Hill, Roll Call, and Politico. Read the full press release.
